Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.

Forty-four patients with relapsed or resistant Hodgkin's disease were treated with adriamycin 40 mg m-2 i.v. on day 1, vincristine 1.4 mg m-2 i.v. on days 1 and 8, prednisolone 40 mg m-2 orally daily for 8 days, etoposide 200 mg m-2 orally daily for 4 days according to the nadir white cell coun...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Perren, T. J., Selby, P. J., Milan, S., Meldrum, M., McElwain, T. J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 1990
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971698/
https://ncbi.nlm.nih.gov/pubmed/1695523
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky